Case: Co-creating a Patient Support Program

Situation

A company is developing a new medical product for patients with a rare disease. Additional services, e.g. a patient-support-program (PSP), are considered important to help patients gaining access to new treatments when needed.

 

There is a lack of knowledge about what program elements will be helpful for patients and relatives, what would be just “nice-to-have” and what can be potentially be perceived as inappropriate.

 

 

Our Solution

  1. Problem Analysis, Patient Segmentation, and Program Targeting
  2. Identification of best partners among patient experts
  3. Co-creation session prepared and moderated by admedicum
  4. Challenging status quo and identifying need-gaps
  5. Brainstorming opportunities for further improvements of program components
  6. Validation among “normal patients”

Results

  • Strong basis for a PSP that truly benefits patients and achieves the client’s goals

Supporting Patient Access to Treatment

In order for the European Medicines Agency to maintain the marketing authorization for mexiletine, data was necessary to evaluate the use and access to mexiletine across Europe.

Internal Patient Engagement Roadmap Workshop

The client wants to better understand and evaluate the ROI of potential patient engagement activities to initiate

Mapping the Patient Landscape

Understanding the major players on the national or European level